Clarity for patients with a liver adenoma, without a liver biopsy.

Clarity for patients with a liver adenoma, without a liver biopsy. - ClaLiBi

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON57469

Enrollment

Registered

2025-05-01

Start date

2025-11-13

Completion date

Unknown

Last updated

2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver adenoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adults with a liver adenoma, or being suspected of having a liver adenoma based on imaging.

Exclusion criteria

Exclusion criteria: Children; adults whom cannot consent or those who do not consent after being informed.

Design outcomes

Primary

Measure	Time frame
Degree of sensitivity and specificity of detecting exon 3 mutations in circulating CTNNB1 in patients with a liver adenoma of at least 3 centimeters.	—

Secondary

Measure	Time frame
Correlation of the sensitivity with the size of the liver adenoma, the type of mutation, the percentage of abnormal cells in the liver biopsy.	—

Countries

Netherlands

Outcome results